A phase IV clinical trial of gastrointestinal motility in adult patients with migraine before and after initiation of a calcitonin gene‐related peptide ligand (galcanezumab) or receptor (erenumab) antagonist
- DOI
- 10.1111/head.14390
- Published
- 2022-09-16
- Container
- Headache: The Journal of Head and Face Pain
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1111/head.14390,
title = {A phase IV clinical trial of gastrointestinal motility in adult patients with migraine before and after initiation of a calcitonin gene‐related peptide ligand (galcanezumab) or receptor (erenumab) antagonist},
author = {David Kudrow and Linda Nguyen and Jack Semler and Chad Stroud and Karen Samaan and Deirdre B. Hoban and Linda Wietecha and Hai‐An Hsu and Eric Pearlman},
year = {2022},
journal = {Headache: The Journal of Head and Face Pain},
doi = {10.1111/head.14390},
url = {https://doi.org/10.1111/head.14390}
}RIS
TY - JOUR TI - A phase IV clinical trial of gastrointestinal motility in adult patients with migraine before and after initiation of a calcitonin gene‐related peptide ligand (galcanezumab) or receptor (erenumab) antagonist AU - David Kudrow AU - Linda Nguyen AU - Jack Semler AU - Chad Stroud AU - Karen Samaan AU - Deirdre B. Hoban AU - Linda Wietecha AU - Hai‐An Hsu AU - Eric Pearlman PY - 2022 JO - Headache: The Journal of Head and Face Pain DO - 10.1111/head.14390 UR - https://doi.org/10.1111/head.14390 ER -
APA
Kudrow, D., Nguyen, L., Semler, J., Stroud, C., Samaan, K., Hoban, D. B., Wietecha, L., Hsu, H., & Pearlman, E. (2022). A phase IV clinical trial of gastrointestinal motility in adult patients with migraine before and after initiation of a calcitonin gene‐related peptide ligand (galcanezumab) or receptor (erenumab) antagonist. Headache: The Journal of Head and Face Pain. https://doi.org/10.1111/head.14390
Source records
- crossref · retrieved 2026-09-26T12:41:57.532Z